학술논문
Randomized, open-label, cross-over, phase-3 study to evaluate efficacy and safety of LIB003 compared with evolocumab in homozygous familial hypercholesterolaemia patients on stable lipid-lowering therapy (liberate-HOFH)
Document Type
Abstract
Author
Source
In Atherosclerosis August 2023 379 Supplement 1:S24-S25
Subject
Language
ISSN
0021-9150